Answers are grounded in this paper and cite their sources.
Background Interdigitating dendritic cell sarcoma (IDCS) is an extremely rare malignant tumor originating from dendritic cells, and primary involvement of the parotid gland is particularly uncommon. Due to its rarity, IDCS of the parotid gland is prone to misdiagnosis, and there is currently a lack of standardized treatment strategies. Case presentation A 67-year-old man presented with painful swelling of the right parotid gland for more than 1 month and was initially diagnosed with a parotid abscess at an outside hospital. Imaging suggested a malignant parotid tumor with cervical lymph node involvement. Histopathological and immunohistochemical examination of the resected specimen confirmed the diagnosis of IDCS. The patient received postoperative radiotherapy and chemotherapy. Approximately 15 months after surgery, follow-up computed tomography revealed multiple metastatic lesions in the lungs, liver, and omentum. Despite subsequent salvage treatment, the disease progressed, and the patient died in March 2025, with an overall survival of 22 months from pathological diagnosis. Conclusions Primary IDCS of the parotid gland is rare and diagnostically challenging. Histopathological and immunohistochemical examinations are essential for accurate diagnosis, and further studies are needed to establish optimal treatment strategies.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: